Other News To Note
Tuesday, May 29, 2012
RegeneRx Biopharmaceuticals Inc., of Rockville, Md., reported preclinical data showing thymosin beta 4 (TB4) provided both neuroprotection and neurorestoration after traumatic brain injury. A study comparing TB4 with saline administration six hours post-injury in rats significantly improved sensorimotor functional recovery and spatial learning, reduced cortical lesion volume and hippocampal cell loss, and enhanced cell proliferation and neurogenesis in the injured hippocampus. The data were published in the May 2012 edition of the Journal of Neurosurgery.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.